These results demonstrated that the number of CD8+ TRM cells increased in DN-CML patients but there was no difference in the TKI-F and MR groups compared to HIs (Figure 3B). Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.